# Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)

> **NCT00844922** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 16 (actual)

## Conditions studied

- Depressive Disorders
- Psychotic Disorders
- Depression

## Interventions

- **DRUG:** SCH 900636
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00844922
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00844922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00844922, "Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00844922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*